EUVIMEDEUVIMED entdecken
Open Access

Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing

Emily L Han, Marshall S Padilla iD, Rohan Palanki iD, Dongyoon Kim, Kaitlin Mrksich, Jacqueline J Li iD, Sophia Tang, Il-Chul Yoon, Michael J Mitchell iD

Nano Letters · 07.02.2024 · 24 (5) · 1477-1486

DOI: 10.1021/acs.nanolett.3c03509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, online erschienen am 23.01.2024. Verfasst von Emily L Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Nanoparticles, Liposomes. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticle (LNP)-mediated nucleic acid therapies, including mRNA protein replacement and gene editing therapies, hold great potential in treating neurological disorders including neurodegeneration, brain cancer, and stroke. However, delivering LNPs across the blood-brain barrier (BBB) after systemic administration remains underexplored. In this work, we engineered a high-throughput screening transwell platform for the BBB (HTS-BBB), specifically optimized for screening mRNA LNPs. Unlike most transwell assays, which only assess transport across an endothelial monolayer, HTS-BBB simultaneously measures LNP transport and mRNA transfection of the endothelial cells themselves. We then use HTS-BBB to screen a library of 14 LNPs made with structurally diverse ionizable lipids and demonstrate it is predictive of in vivo performance by validating lead candidates for mRNA delivery to the mouse brain after intravenous injection. Going forward, this platform could be used to screen large libraries of brain-targeted LNPs for a range of protein replacement and gene editing applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierNanoparticlesLiposomesAnimalsMiceEndothelial CellsRNA, MessengerLipidsTransfectionRNA, Small Interfering

Stichwörter der Autor:innen

blood−brain barrierbrain deliverylipid nanoparticlemRNA

Substanzen

Lipid NanoparticlesRNA, MessengerLipidsRNA, Small InterferingLiposomes

Autor:innen und Institutionen

  • Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Center for Fetal Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.
  • Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

ORCID-Profile: Marshall S Padilla, Rohan Palanki, Jacqueline J Li, Michael J Mitchell

Förderung

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NIDCR NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute of Dental and Craniofacial Research
  • Division of Graduate Education
  • NHLBI Division of Intramural Research
  • American Cancer Society

Zitieren

APA

Han, E. L., Padilla, M. S., Palanki, R., Kim, D., Mrksich, K., Li, J. J., Tang, S., Yoon, I. C., & Mitchell, M. J. (2024). Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing. Nano Letters, 24(5), 1477-1486. https://doi.org/10.1021/acs.nanolett.3c03509

Vancouver

Han EL, Padilla MS, Palanki R, Kim D, Mrksich K, Li JJ, et al. Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing. Nano Letters. 2024;24(5):1477-1486. doi:10.1021/acs.nanolett.3c03509

BibTeX
@article{Han2024,
  author = {Han, Emily L and Padilla, Marshall S and Palanki, Rohan and Kim, Dongyoon and Mrksich, Kaitlin and Li, Jacqueline J and Tang, Sophia and Yoon, Il-Chul and Mitchell, Michael J},
  title = {Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing},
  journal = {Nano Letters},
  year = {2024},
  volume = {24},
  number = {5},
  pages = {1477--1486},
  doi = {10.1021/acs.nanolett.3c03509}
}
Kostenlos starten →